From Tokyo Hospital to American Clinics: A Therapy With a 50-Year Track Record
From Tokyo Hospital to American Clinics: A Therapy With a 50-Year Track Record
Blood Flow Restriction therapy may seem relatively new in American rehabilitation, but its clinical roots extend back more than 50 years. The method that became KAATSU was being used with people of all ages in Tokyo in the 1970s, entered formal scientific literature in 2000, and later contributed to the broader BFR approaches now used in clinics, sports medicine, and rehabilitation programs around the world.
One important figure in that development was Johnny Owens, who worked with rehabilitation of military personnel at Brooke Army Medical Center and helped introduce BFR approaches using modified blood-pressure cuffs into American rehabilitation practice.
At the same time, American sports science and rehabilitation researchers increasingly began publishing their own work on Blood Flow Restriction.
As adoption increased, the field started to separate into different equipment and protocol traditions.
KAATSU continued to use its narrow elastic pneumatic bands and cycled-pressure methodology, while other BFR systems increasingly used wider cuffs, limb occlusion pressure measurements, and sustained-pressure protocols.
By the late 2010s, “BFR” had become a broad clinical category rather than the name of one standardized method.
2020s — BFR Becomes a Broader Rehabilitation Category
Today, multiple forms of Blood Flow Restriction are used in rehabilitation and performance settings.
Reported applications include:
-
Physical therapy clinics
-
Longevity-focused biohacking practices
-
Military and special operations rehabilitation
- General strength and conditioning
- Olympic-level training
The published literature across the broader BFR category now includes a large body of peer-reviewed research examining muscle, strength, rehabilitation, vascular responses, and other physiological effects.
KAATSU equipment remains in use within many of these settings.
Dr. Yoshiaki Sato continues to be associated with KAATSU education in Japan, while Steven Munatones, CEO of KAATSU Global, oversees the company's American program.
Why the Clinical Timeline Matters
The history matters because it changes how clinicians and patients should interpret both research and marketing.
Blood Flow Restriction therapy did not begin when American clinics started using the term BFR.
The underlying KAATSU method had already been used in Japan for decades, and clinical research had begun well before the broader American market developed.
That does not mean every modern BFR product should be treated as equivalent to KAATSU.
In fact, the opposite is true.
As the field expanded, different cuffs, pressures, exercise structures, and clinical protocols emerged. A clinician reading a BFR study therefore needs to know which method was actually tested rather than treating every paper carrying the BFR label as evidence for every device or protocol.
The clinical record is long enough that the field should not be discussed as though it appeared only recently.
At the same time, a long history is not a reason to oversell individual outcomes. Clinical claims should still be tied to the specific population, equipment, protocol, and research being discussed.
Where to Read the Original Research
For clinicians and patients who want to examine the original sources, several publications are useful starting points.
The 2000 Journal of Applied Physiology paper documenting muscular adaptations with moderate vascular occlusion remains one of the foundational publications.
A March 2022 letter by Sato and Nakajima also summarizes the period of research associated with the University of Tokyo Hospital between 2004 and 2014.
We are happy to share these references with patients, clinicians, and members of a care team who want to evaluate the method more closely.
Want to learn more about KAATSU and Blood Flow Restriction? Reach out to our team at info@kaatsu.com for further guidance on equipment, protocols, research, and use.
